Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

maruho co.,ltd. - heparinoid - white cream

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer plc - heparinoid hyaluronidase - ointment - 5000/15000 %v/v

Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - ibuprofen, heparinoid - cream - ibuprofen 1.5 g heparinoid 60 mg - topical products for joint and muscular pain

Malta - English - Medicines Authority

opella healthcare france sas t/a sanofi 157 avenue charles de gaulle, 92200 neuilly-sur-seine , france - ibuprofen, heparinoid - cream - ibuprofen 50 mg heparinoid 2 mg - topical products for joint and muscular pain

Australia - English - Department of Health (Therapeutic Goods Administration)

heparin sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 5000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 1000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - heparin sodium 5000 iu/ml;   - solution for injection - 25000 iu/5ml - active: heparin sodium 5000 iu/ml   excipient: hydrochloric acid sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - heparin sodium 1000 iu/ml;   - solution for injection - 5000 iu/5ml - active: heparin sodium 1000 iu/ml   excipient: hydrochloric acid sodium hydroxide water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - heparin sodium, quantity: 2000 iu/l - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.